Phase2 Study of TS-091 in Patients With Narcolepsy
Latest Information Update: 07 Dec 2021
At a glance
- Drugs TS 091 (Primary)
- Indications Narcolepsy
- Focus Therapeutic Use
- Sponsors Taisho Pharmaceutical
- 28 Jul 2016 Status changed from recruiting to completed.
- 06 Jun 2016 New trial record